Abstract
A boy with congenital rubella syndrome developed dysgammaglobulinaemia with elevated serum levels of IgM. CD154 was not induced on his peripheral blood mononuclear cells when rubella virus RNA was detected in his throat swabs and peripheral blood by reverse transcriptase polymerase chain reaction. Following intravenous immunoglobulin therapy, improvement of immunoglobulin abnormalities, disappearance of rubella virus and normalisation of CD154 expression were demonstrated.
Conclusion These findings implicate the efficacy of intravenous immunoglobulin therapy for dysgammaglobulinaemia in congenital rubella syndrome and a role of CD154 for a prolonged virus infection.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 8 March 2000 / Accepted: 25 April 2000
Rights and permissions
About this article
Cite this article
Kawamura, N., Okamura, A., Furuta, H. et al. Improved dysgammaglobulinaemia in congenital rubella syndrome after immunoglobulin therapy: correlation with CD154 expression. Eur J Pediatr 159, 764–766 (2000). https://doi.org/10.1007/PL00008342
Issue Date:
DOI: https://doi.org/10.1007/PL00008342